What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “Prismocitrate 18 solution (investigational drug) will be used in pre-dilution mode only; the rate of administration depends on the targeted citrate dose and the prescribed flow rate. The pre-filter infusion rate of Prismocitrate 18 solution will be indexed to the blood flow rate (BFR) to achieve a target blood citrate concentration of 3 mmol/L of blood. The flow rate for the anticoagulation of…”In the company’s words, NCT05399537 on ClinicalTrials.gov
- Tested for
- Regional Citrate Anticoagulation (RCA), Continuous Renal Replacement Therapy (CRRT), Acute Kidney Injury (AKI)
- Main trialPhase 3
- “Prismocitrate 18 is a continuous renal replacement therapy (CRRT) solution to be used as a renal replacement solution and as an anticoagulant to prevent blood clotting in the extracorporeal circuit. The delivery of CRRT therapy is provided by the PrisMax System which includes regional citrate anticoagulation (RCA) software to facilitate citrate and calcium compensation prescription. The objectives of this study are: 1) to confirm the safety of Prismocitrate 18 in patients receiving CRRT using continuous venovenous hemodiafiltration (CVVHDF) or continuous venovenous hemofiltration (CVVH) and…”In the company’s words, NCT05399537 on ClinicalTrials.gov
Other drugs for Acute Kidney Injury (AKI)
- QRX-3Ebima Clifford Okundaye · Phase 2/3
- AZD4144AstraZeneca · Phase 2
- LSALT peptideArch Biopartners Inc. · Phase 2
- R2R01River 2 Renal Corp. · Phase 2
- CSL889CSL Behring · Phase 2
- Allogeneic HB-adMSCsHope Biosciences LLC · Phase 1/2
Coming up1
- Jan 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | Jan 2027 | Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT | |
| Phase 3Terminated | 12 May 2018 | Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026